2023 Annual Meeting | C175 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Date Wednesday 04/26/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jennifer Graves, MD, PhD

Topic(s) Child Neurology and Developmental Neurology, Multiple Sclerosis

Learning Objectives Participants should be able to understand the approach to the diagnosis of Pediatric MS and unique features of the disease in children; summarize current literature regarding treatments for acute relapses and for disease modulation; and address symptomatic management, cognitive symptoms, mental wellness and physical activity, and strategies for rehabilitation.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 04:00 PM EST	Speaker	Unique Features of Pediatric MS and Overview of the Therapeutic Landscape Jennifer Graves, MD, PhD
04:00 PM - 04:30 PM EST	Speaker	The Nuts and Bolts of Disease-modifying Therapies in Children Jennifer H. Yang, MD
04:30 PM - 05:00 PM EST	Speaker	Beyond DMTs: Symptom Management, Physical Activity and Mental Wellness in Pediatric MS James N. Brenton, MD
05:00 PM - 05:30 PM EST	Discussion	Questions, Answers, and Case Examples Jennifer Graves, MD, PhD, James N. Brenton, MD, Jennifer H. Yang, MD

Faculty Disclosures
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
James N. Brenton, MD	Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Jennifer H. Yang, MD	Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. Dr. Yang has received research support from NIH.

��ɫ��

��ɫ��